Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2010 1
2011 4
2012 2
2013 2
2014 2
2015 3
2017 1
2018 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Safety of long-term simvastatin discontinuation.
Puccetti L, Scarpini F, Cappellone R, Auteri A. Puccetti L, et al. Among authors: scarpini f. Lancet. 2012 May 5;379(9827):1704; author reply 1704. doi: 10.1016/S0140-6736(12)60719-3. Lancet. 2012. PMID: 22559898 No abstract available.
Genetic influence in statin intolerance.
Puccetti L, Scarpini F, Cappellone R, Auteri A. Puccetti L, et al. Among authors: scarpini f. Clin Pharmacol Ther. 2011 Sep;90(3):365. doi: 10.1038/clpt.2011.114. Epub 2011 Jul 13. Clin Pharmacol Ther. 2011. PMID: 21753748 No abstract available.
Role of genetic factors in statins side-effects.
Scarpini F, Cappellone R, Auteri A, Puccetti L. Scarpini F, et al. Cardiovasc Hematol Disord Drug Targets. 2012 Sep;12(1):35-43. doi: 10.2174/187152912801823138. Cardiovasc Hematol Disord Drug Targets. 2012. PMID: 22524173
Genetic influence in liver steatosis prevalence and proatherothrombotic/inflammatory profile in familial combined hyperlipoproteinemia.
Santilli F, Blardi P, Scarpini F, Acciavatti A, Ceccatelli L, Magliocca A, Avolio T, Bocchia M, Scapellato C, Gioffrè WR, Auteri A, Ferracane SC, Puccetti L. Santilli F, et al. Among authors: scarpini f. Int J Cardiol. 2013 Sep 20;168(1):536-9. doi: 10.1016/j.ijcard.2013.01.250. Epub 2013 Mar 7. Int J Cardiol. 2013. PMID: 23465229 No abstract available.
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.
Raparelli V, Pastori D, Pignataro SF, Vestri AR, Pignatelli P, Cangemi R, Proietti M, Davì G, Hiatt WR, Lip GYH, Corazza GR, Perticone F, Violi F, Basili S; ARAPACIS Study Collaborators. Raparelli V, et al. Intern Emerg Med. 2018 Aug;13(5):651-660. doi: 10.1007/s11739-018-1835-9. Epub 2018 Mar 26. Intern Emerg Med. 2018. PMID: 29582316
Relationship between carotid intima-media thickness and non valvular atrial fibrillation type.
Proietti M, Calvieri C, Malatino L, Signorelli S, Corazza GR, Perticone F, Vestri AR, Loffredo L, Davì G, Violi F, Basili S; ARAPACIS (Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study) STUDY Investigators. Proietti M, et al. Atherosclerosis. 2015 Feb;238(2):350-5. doi: 10.1016/j.atherosclerosis.2014.12.022. Epub 2014 Dec 20. Atherosclerosis. 2015. PMID: 25555267
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia.
Puccetti L, Santilli F, Pasqui AL, Lattanzio S, Liani R, Ciani F, Ferrante E, Ciabattoni G, Scarpini F, Ghezzi A, Auteri A, Davì G. Puccetti L, et al. Among authors: scarpini f. Atherosclerosis. 2011 Jan;214(1):122-8. doi: 10.1016/j.atherosclerosis.2010.10.006. Epub 2010 Nov 5. Atherosclerosis. 2011. PMID: 21056418 Clinical Trial.
15 results